Clinical Trials Browser

Phase 1/2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × camrelizumab × Clear all

NCT06376721 2024-04-19

Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma

Phase 1/2 Recruiting

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma